Key Facts

Big Health was founded in 2010 by Prof. Colin Espie and Peter Hames. 13 Randomised Controlled Trials completed on our two treatments Sleepio and Daylight. In a placebo-controlled trial, 76% of Sleepio users moved from unhealthy to healthy levels of sleep efficiency. In Daylight’s first RCT, 71% of Daylight users moved from clinical to non-clinical levels of anxiety. 75,000 UK residents have entered treatment with our products. The business operates in the US and the UK. Total employees = c. 140

Successes in UK/NHS

In 2021, NHS Scotland funded nationwide access to Sleepio and Daylight for all Scottish residents until 2023, after a successful Test of Change run Jan-Aug 2021. Since Jan 2021, c. 2k Scottish residents have entered treatment. People using Sleepio gained on average c. 7 hours' additional sleep per week. C. 70% of people using Daylight experienced an improvement in their anxiety symptoms. In 2020, NHS England partnered with Big Health during the Covid-19 pandemic to provide Sleepio and Daylight to all NHS staff in England. >18k staff entered treatment between Mar 2020 and Jul 2021. Sleepio all time data: - 67,000 UK residents have entered treatment with Sleepio (2012-present) Daylight all time data: - 8,000 UK residents have entered treatment with Daylight (2020-present)

Company details

Solutions

Delivering advanced patient care

Enabling self-care

Specialism

Digitally-enabled out of hospital care

Mental health

Company details

Want to connect with this innovator?

Make an enquiry

Markets already exporting to

- United States (where Big Health has an office)

Desired Markets

- Canada - Australia - New Zealand - Germany

Desired customer types

- Health systems / health plans - Insurance providers - Employers

Want to connect with this innovator?
Make an enquiry
Close
This field is required
This field is required
This field is required
This field is required
This field is required

Thank you

We are processing your request and will return your contact as soon as possible.